OSCR

Selective TRPV2 Antagonists Derived from the Natural Product Piperlongumine Inhibit Cancer Cell Migration and Metastasis.

Overview

Authors: Hannah Kiely-Collins1, Cong Tang2, Marta C Marques2, Laura Butron3, Angela Lamberti3, Nicholas Bossons4,5, Fabian Offensperger6, Vincenth Brennsteiner6, Bárbara Sousa2, Luís Carvalho1, Antonio Ferrer-Montiel3, Francisco Corzana7, Georg E Winter6, Asia Fernandez-Carvajal3, Gonçalo J L Bernardes1,8
  1. Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, U.K
  2. GIMM - Gulbenkian Institute for Molecular Medicine, Avenida Prof. Egas Moniz, Lisboa 1649-028, Portugal
  3. Instituto de Investigación, Desarrollo e Innovación en Biotecnología Sanitaria de Elche (IDiBE), Universidad Miguel Hernandez, Avda. Universidad s/n, Elche 03202, Spain
  4. Chemprecise Lda, Torres Vedras 2560-247, Portugal
  5. Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon 1649-003, Portugal
  6. CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna 1090, Austria
  7. Departamento de Química, Universidad de La Rioja, Instituto de Investigación en Química (IQUR), Logroño 26006, Spain
  8. Translational Chemical Biology Group, Spanish National Cancer Research Centre 26 (CNIO), Madrid 28029, Spain
Journal: ACS chemical biology, volume 21, issue 4, pages 674-688
Dates: received 24 November 2025; accepted 16 March 2026; published online 25 March 2026; in print April 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1021/acschembio.5c00935 · PMID 41879799 · PMCID PMC13097083 · OpenAlex W7140302404
Open access: hybrid, a free copy (OpenAlex)
Categories: human (organism), other condition (population), cellular / molecular (subfield)
MeSH: Antineoplastic Agents*, Biological Products*, Cell Movement*, Dioxolanes*, TRPV Cation Channels*, Animals, Cell Line, Tumor, HEK293 Cells, Humans, Neoplasm Metastasis, Piperidones (* major topic)
Topic: Piperaceae Chemical and Biological Studies (Pharmacology, Pharmacology, Toxicology and Pharmaceutics), according to OpenAlex
Funding: Generalitat Valenciana (PID2021-126423OB-C21, PROMETEO/2021/031); Universidad de La Rioja (REGI25/45, REGI22/16); Biotechnology and Biological Sciences Research Council; Fundação para a Ciência e a Tecnologia (2022.08101.CEECIND); European Commission; Agencia Estatal de Investigación (PID2021-127622OB- I00, 13039, PID2024-161682OB-I00, PID2021-126423OB-C21, AEI/10, PID2021); H2020 Marie Skłodowska-Curie Actions (956477)
Citations: not cited yet (Europe PMC); 85 references in the paper

Abstract

TRPV2 is the least studied member of the vanilloid TRP subfamily despite its emerging relevance in cancer metastasis, pain, and inflammation. Although several small-molecule TRPV2 modulators have been reported, including the natural products piperlongumine (PL) and cannabidiol, all lack selectivity, complicating the interpretation of phenotypic readouts and functional insights into the role of the channel in health and disease. Here, we report a series of PL-based derivatives rationally designed to maintain TRPV2 antagonism while eliminating covalent off-target activity associated with the electrophilic groups present in PL. Using electrophysiological and calcium fluorescence imaging assays in HEK293T cells and DRG nociceptors, we identified HKC54 as the most potent TRPV2 antagonist to date (IC50 = 0.4 μM), displaying ∼50-fold selectivity over TRPV1 and ∼70-fold selectivity over TRPA1. Cellular thermal shift assays demonstrated direct TRPV2 engagement, and molecular dynamics and docking studies suggest a near-identical binding mode of the derivatives to PL. To assess proteome-wide selectivity, we pursued an unbiased chemoproteomic strategy and developed photoaffinity probes derived from PL and noncovalent derivative HKC22. Whereas the PL-based probe labeled many established covalent and noncovalent PL targets (e.g., GSTP1, GSTO1, STAT3, and KEAP1), no off-targets were detected for HKC22, suggesting high selectivity for TRPV2. Finally, PL derivatives inhibited cancer cell migration in vitro and suppressed metastasis in vivo, underscoring the therapeutic potential of selective TRPV2 antagonists.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 30 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 15 authors, 11 MeSH terms, 7 funders, 79 references.

Cite

This paper

Kiely-Collins, H., Tang, C., Marques, M. C., Butron, L., Lamberti, A., Bossons, N., Offensperger, F., Brennsteiner, V., Sousa, B., Carvalho, L., Ferrer-Montiel, A., Corzana, F., Winter, G. E., Fernandez-Carvajal, A., & Bernardes, G. J. L. (2026). Selective TRPV2 Antagonists Derived from the Natural Product Piperlongumine Inhibit Cancer Cell Migration and Metastasis. ACS chemical biology, 21(4), 674-688. https://doi.org/10.1021/acschembio.5c00935

BibTeX

@article{kielycollins2026selective,
author = {Kiely-Collins, Hannah and Tang, Cong and Marques, Marta C and Butron, Laura and Lamberti, Angela and Bossons, Nicholas and Offensperger, Fabian and Brennsteiner, Vincenth and Sousa, Bárbara and Carvalho, Luís and Ferrer-Montiel, Antonio and Corzana, Francisco and Winter, Georg E and Fernandez-Carvajal, Asia and Bernardes, Gonçalo J L},
title = {{Selective TRPV2 Antagonists Derived from the Natural Product Piperlongumine Inhibit Cancer Cell Migration and Metastasis}},
journal = {ACS chemical biology},
year = {2026},
month = mar,
volume = {21},
number = {4},
pages = {674--688},
publisher = {American Chemical Society},
issn = {1554-8929},
doi = {10.1021/acschembio.5c00935},
url = {https://doi.org/10.1021/acschembio.5c00935},
pmid = {41879799},
pmcid = {PMC13097083}
}

RIS

TY - JOUR
AU - Kiely-Collins, Hannah
AU - Tang, Cong
AU - Marques, Marta C
AU - Butron, Laura
AU - Lamberti, Angela
AU - Bossons, Nicholas
AU - Offensperger, Fabian
AU - Brennsteiner, Vincenth
AU - Sousa, Bárbara
AU - Carvalho, Luís
AU - Ferrer-Montiel, Antonio
AU - Corzana, Francisco
AU - Winter, Georg E
AU - Fernandez-Carvajal, Asia
AU - Bernardes, Gonçalo J L
TI - Selective TRPV2 Antagonists Derived from the Natural Product Piperlongumine Inhibit Cancer Cell Migration and Metastasis
T2 - ACS chemical biology
J2 - ACS Chem Biol
PY - 2026
DA - 2026/03/25
VL - 21
IS - 4
SP - 674
EP - 688
SN - 1554-8929
PB - American Chemical Society
DO - 10.1021/acschembio.5c00935
UR - https://doi.org/10.1021/acschembio.5c00935
LA - en
ER -

CSL-JSON

{
"id": "10.1021/acschembio.5c00935",
"type": "article-journal",
"title": "Selective TRPV2 Antagonists Derived from the Natural Product Piperlongumine Inhibit Cancer Cell Migration and Metastasis",
"container-title": "ACS chemical biology",
"author": [
{
"family": "Kiely-Collins",
"given": "Hannah"
},
{
"family": "Tang",
"given": "Cong"
},
{
"family": "Marques",
"given": "Marta C"
},
{
"family": "Butron",
"given": "Laura"
},
{
"family": "Lamberti",
"given": "Angela"
},
{
"family": "Bossons",
"given": "Nicholas"
},
{
"family": "Offensperger",
"given": "Fabian"
},
{
"family": "Brennsteiner",
"given": "Vincenth"
},
{
"family": "Sousa",
"given": "Bárbara"
},
{
"family": "Carvalho",
"given": "Luís"
},
{
"family": "Ferrer-Montiel",
"given": "Antonio"
},
{
"family": "Corzana",
"given": "Francisco"
},
{
"family": "Winter",
"given": "Georg E"
},
{
"family": "Fernandez-Carvajal",
"given": "Asia"
},
{
"family": "Bernardes",
"given": "Gonçalo J L"
}
],
"container-title-short": "ACS Chem Biol",
"volume": "21",
"issue": "4",
"page": "674-688",
"DOI": "10.1021/acschembio.5c00935",
"PMID": "41879799",
"PMCID": "PMC13097083",
"ISSN": "1554-8929",
"publisher": "American Chemical Society",
"URL": "https://doi.org/10.1021/acschembio.5c00935",
"language": "en",
"issued": {
"date-parts": [
[
2026,
3,
25
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1038/s41467-022-35163-y
Cannabinoid non-cannabidiol site modulation of TRPV2 structure and function.
Journal: Nature communications
In common: cellular / molecular, 10 references
[2] doi:10.1016/j.molpha.2025.100060
Molecular determinants of 2-aminoethoxydiphenyl borate sensitivity of transient receptor potential vanilloid 2-unexpected differences between 2 rodent orthologs.
Journal: Molecular pharmacology
In common: cellular / molecular, 7 references
[3] doi:10.1038/s41467-026-76831-7
Structural origins of species-specific differences in TRPV2 activation.
Journal: Nature communications
In common: cellular / molecular, 4 references
[4] doi:10.7554/elife.78301
Tyrosine phosphorylation tunes chemical and thermal sensitivity of TRPV2 ion channel.
Journal: eLife
In common: cellular / molecular, 3 references
[5] doi:10.1080/15548627.2024.2439649
Autophagy induction by piplartine ameliorates axonal degeneration caused by mutant HSPB1 and HSPB8 in Charcot-Marie-Tooth type 2 neuropathies.
Journal: Autophagy
In common: other condition, cellular / molecular, 2 references
[6] doi:10.1038/s41467-025-61562-y [code]
A dedicated skin-to-brain circuit for cool sensation in mice.
Journal: Nature communications
In common: 3 references
[7] doi:10.1016/j.crmeth.2022.100341
Derivation of nociceptive sensory neurons from hiPSCs with early patterning and temporally controlled <i>NEUROG2</i> overexpression.
Journal: Cell reports methods
In common: cellular / molecular, 2 references
[8] doi:10.1126/sciadv.adn0367
Remote neurostimulation through an endogenous ion channel using a near-infrared light-activatable nanoagonist.
Journal: Science advances
In common: cellular / molecular, 2 references
[9] doi:10.3390/ijms24021428 [code]
Molecular Landscape of Tourette's Disorder.
Journal: International journal of molecular sciences
In common: other condition, cellular / molecular, 2 references
[10] doi:10.1016/j.bbadva.2024.100130
Valosin-containing protein (VCP), a component of tumor-derived extracellular vesicles, impairs the barrier integrity of brain microvascular endothelial cells.
Journal: BBA advances
In common: other condition, cellular / molecular, 2 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.